DCO Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ducommun (DCO) is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 who is impatient and wants to act now. The stock has solid long-term fundamentals and improving analyst sentiment, but the current setup is mixed: technical momentum is weakening, insider selling is elevated, and there is no fresh news catalyst. If forced to choose today, hold is the better call rather than buy.
The current price is 137.74, just below pivot resistance at 141.762 and above S1 support at 136.672. The medium-term trend is constructive because SMA_5 > SMA_20 > SMA_200, which is bullish. However, MACD histogram is -0.505 and expanding negatively, showing short-term momentum deterioration. RSI_6 at 43.461 is neutral-to-weak, not oversold enough to signal a compelling entry. Overall, the trend is mildly bullish structurally but currently losing momentum.
["Analysts have recently raised price targets across multiple firms, with Goldman Sachs, RBC, Citi, B. Riley, and Truist all maintaining Buy/Outperform-style views.", "Q4 2025 financials were strong: revenue up 9.38% YoY, net income up 9.89% YoY, EPS up 11.11% YoY, and gross margin improved to 27.71%.", "Backlog and defense-related demand remain supportive based on analyst commentary, especially missile and military exposure.", "Bullish options sentiment with low put-call ratios and active call interest.", "The moving average structure is bullish (SMA_5 > SMA_20 > SMA_200)."]
["No news in the recent week, so there is no fresh event-driven catalyst.", "MACD is negative and worsening, indicating short-term momentum weakness.", "Insiders are selling, and the selling amount increased 2820.20% over the last month.", "The stock is trading below the pivot level, showing it has not reclaimed key near-term resistance.", "There is no recent congress trading data to support a politically driven buying signal.", "Earnings are upcoming on 2026-05-12 pre-market, which adds event risk for near-term entry."]
Latest quarter shown is Q4 2025. Ducommun posted revenue of $215.8M, up 9.38% YoY, net income of $7.44M, up 9.89% YoY, EPS of $0.50, up 11.11% YoY, and gross margin of 27.71%, up 14.79% YoY. This is a healthy growth profile with margin expansion, which supports the long-term case.
Analyst sentiment has trended positive overall. Goldman Sachs raised its target to $151 and kept Buy; Citi trimmed slightly to $141 but kept Buy; RBC raised to $150 and kept Outperform; B. Riley lifted to $155 and kept Buy; Truist raised to $136 and kept Buy; RBC also previously raised to $142. The Wall Street pros are broadly bullish on the name, mainly because of defense exposure, backlog visibility, and margin improvement. The main con is that some near-term commercial aerospace growth remains muted due to 737 MAX destocking, so upside is more dependent on defense/missile acceleration than broad-based growth.
